Pathobiology of the heart in experimental diabetes: Immunolocalization of lipoproteins, immunoglobulin G, and advanced glycation endproducts proteins in diabetic and/or hyperlipidemic hamster

Laboratory Investigation

Volumn 77, Issue 1, 1997, Pages 3-18

  Sima, Anca ^a   Popov, Doina ^a   Starodub, Olga ^a   Stancu, Camelia ^a   Cristea, Carmen ^a   Stern, David ^b   Simionescu, Maya ^a  

^a INSTITUTE OF CELLULAR BIOLOGY AND PATHOLOGY NICOLAE SIMIONESCU   (Romania)

^b Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; GLYCOSYLATED PROTEIN; IMMUNOGLOBULIN G; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROSCLEROSIS; CARDIOMYOPATHY; CONTROLLED STUDY; EXPERIMENTAL DIABETES MELLITUS; HYPERGLYCEMIA; HYPERLIPIDEMIA; IMMUNOHISTOCHEMISTRY; NONHUMAN; PRIORITY JOURNAL; SYRIAN HAMSTER; VASCULAR DISEASE;

ANIMALS; AORTA, THORACIC; CORONARY CIRCULATION; CORONARY VESSELS; CRICETINAE; DIABETES MELLITUS, EXPERIMENTAL; ENDOTHELIUM, VASCULAR; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; HYPERGLYCEMIA; HYPERLIPIDEMIAS; IMMUNOGLOBULIN G; LIPOPROTEINS; LIPOPROTEINS, LDL; MALE; MESOCRICETUS; MYOCARDIUM;

EID: 0030788194     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Araki T, Shimizu M, Yoshio H, Ino H, Mabuchi H, and Takeda R (1995). Effects of angiotensin-converting enzyme inhibitor and aldosterone agonist on myocardial collagen in cardiomyopathic hamsters. Jpn Circ J 59:213-218.
2. Badimon JJ, Fuster V, Chesebro JH, and Badimon L (1993). Coronary atherosclerosis. A multifactorial disease. Circulation 87(Suppl II):II3-II16.
3. Bradford MM (1976). A rapid sensitive method for the quantitation of microgram quantities of protein using the principle of protein-dye binding. Anal Biochem 72:248-255.
4. Bucala R, Makita Z, Koschinsky T, Cerami A, and Vlassara H (1993). Lipid advanced glycosylation: Pathway for lipid oxidation in vivo. Proc Natl Acad Sci USA 90:6434-6438.
5. Burchfiel CM, Reed DM, Marcus EB, Strong JP, and Hayashi T (1993). Association of diabetes mellitus with coronary atherosclerosis and myocardial lesions. Am J Epidemiol 137:1328-1340.
6. Cogan DG, Toussaint D, and Kuwabara T (1961). Retinal vascular patterns: IV - Diabetic retinopathy. Arch Ophtalmol 66:366-371.
7. Cotran RS, Kumar V, and Robbins SL (1989). Pathologic basis of disease. W. B. Saunders Co. Harcourt Brace Jovanovich, Inc. 643-648(a); 1460(b).
8. Dobrian A and Simionescu M (1995). Irreversibly glycated albumin alters the physico-chemical characteristics of low density lipoproteins of normal and diabetic subjects. Biochim Biophys Acta 1270:26-35.
9. Donahue RP and Orchard TJ (1992). Diabetes mellitus and macrovascular complications. An epidemiologic perspective. Diabetes Care 15:1141-1155.
10. Filip DA, Nistor A, Bulla A, Radu A, Lupu F, and Simionescu M (1987). Cellular events in the development of valvular atherosclerosis lesions induced by experimental hypercholesterolemia. Atherosclerosis 67:199-214.
11. Fitzgerald PJ, Ports TA, and Yock PG (1992). Contribution of localized calcium deposits to dissection after angioplasty: An observational study using intravacular ultrasound. Circulation 86:64-70.
12. Fleckenstein A, Frey M, Zom J, and Fleckenstein-Grin G (1990). Calcium, a neglected key factor in hypertension and atherosclerosis. In: Laragh JH and Brenner BM, editors: Hypertension: Pathophysiology, diagnosis and management. New York: Raven Press, 471-510.
13. Fogelman AM, Schechter I, Seager J, Hokom M, Child JS, and Edwards PA (1986). Malondialdehyde alteration of low density lipoproteins leads to cholesteryl ester accumulation in human monocyte-macrophages. Proc Natl Acad Sci USA 77:2214-2218.
14. Hadcock R, Richardson M, Winocour PD, and Hatton MWC (1991). Intimal alterations in rabbit aortas during the first 6 months of alloxan-induced diabetes. Arterioscler Thrombosis 11:517-529.
15. Hei YJ, Diamond J, and Mc Neill JH (1992). Alterations of G protein function in cardiac tissues from streptozotocininduced chronic diabetic rats. Gen Pharmacol 23:889-896.
16. Heickendorff L, Ledet T, and Rasmussen LM (1994). GAG in the human aorta in diabetes mellitus: A study of tunica media from areas with and without atherosclerosis plaque. Diabetologia 37:286-292.
17. Hoff HF and Bond MG (1983). Apolipoprotein B localization in coronary atherosclerotic plaques from Cynomologus monkeys. Artery 12:104-116.
18. Hogan M, Cerami A, and Bucala R (1992). Advanced glycosylation endproducts block the anti-proliferative effect of nitric oxide. Role in the vascular and renal complications of diabetes mellitus. J Clin Invest 90:1110-1115.
19. Jacody RM and Nesto RW (1992). Acute myocardial infarction in the diabetic patient: Pathomorphology, clinical course and prognosis. J Am Coll Cardiol 20:736-744.
20. Kirstein M, Brett J, Radoff S, Ogawa S, Stern D, and Vlassara H (1990). Advanced protein glycosylation induces transendothelial human monocyte chemotaxis and secretion of platelet-derived growth factor: Role in vascular disease of diabetes and aging. Proc Natl Acad Sci USA 87:9010-9014.
21. Meyer MW and Lind J (1972). Calcification of iliac arteries in newborns and infants. Arch Dis Child 47:364-372.
22. Mora R, Lupu F, and Simionescu N (1987). Colocalization of apolipoprotein B, unesterified cholesterol and extracellular phospholipid liposomes in the aorta of hyperlipidemic rabbit. Atherosclerosis 67:143-154.
23. Nakamura Y, Horii Y, Nishino T, Shiiki H, Sakaguchi Y, Kagoshima T, Dohi K, Makita Z, Vlassara H, and Bucala R (1993). Immunohistochemical localization of AGE products in coronary atheroma and cardiac tissue in diabetes mellitus. Am J Pathol 143:1649-1656.
24. Nathan DM (1993). Long term complications of diabetes mellitus. N Engl J Med 328:1676-1685.
25. Nistor A, Bulla A, Filip DA, and Radu A (1987). The hyperlipidemic hamster as a model of experimental atherosclerosis. Atherosclerosis 68:159-173.
26. Palinski W, Koschinsky T, Butler SW, Miller E, Vlassara H, Cerami A, and Witztum JL (1995). Immunological evidence for the presence of advanced glycosylation end products in atherosclerotic lesions of euglycemic rabbits. Arterioscler Thromb Vasc Res 15:571-582.
27. Popov D, Sima A, Stern D, and Simionescu M (1996). The pathomorphological alterations of endocardial endothelium in experimental diabetes, and diabetes associated with hyperlipidemia. Acta Diabetol 232:1-7.
28. Qiao JH, Xie PZ, Fishbein MC, Kreuzer J, Drake TA, Demer LL, and Lusis AJ (1994). Pathobiology of atheromatous lesions in inbred and genetically engineered mice. Arterioscler Thromb 14:1480-1497.
29. Schmidt AM, Vianna M, Gerlach M, Brett J, Ryan J, Kao J, Esposito C, Hegarty H, Hurley W, Clauss M, Wang F, Pan Y. C, Tsang T. C, and Stern D (1992). Isolation and characterization of two binding proteins for AGE products from bovine lung which are present on the endothelial cell surface. J Biol Chem 267:14987-14997.
30. Schwartz CL, Valente AJ, Sprague EA, Kelley JL, Cayatte A. J, and Rozek M. M. (1992). Pathogenesis of the atherosclerotic lesions. Diabetes Care 15:1159-1167.
31. Sima A, Bulla A, and Simionescu N (1990). Experimental obstructive coronary atherosclerosis in the hyperlipidemic hamster. J Submicrosc Cytol Pathol 22:1-16.
32. Simionescu M, Popov D, Sima A, Hasu M, Costache G, Faitar S, Vulpanovici A, Stancu C, Stern D, and Simionescu N (1995). The hyperlipidemic and diabetic hamster, a novel animal model. In: Woodford FP, Davignon D, and Sniderman A, editors: Atherosclerosis X: Proceedings of the 10th international symposium on atherosclerosis. Amsterdam: Elsevier, 105-110.
33. Simionescu M, Popov D, Sima A, Hasu M, Costache G, Faitar S, Vulpanovici A, Stancu C, Stern D, and Simionescu N (1996). Pathobiochemistry of combined diabetes and atherosclerosis studied on a novel animal model: The hyperlipemic hyperglycemic hamster. Am J Pathol 148:997-1014.
34. Simionescu N, Sima A, Dobrian A, Tîrziu D, and Simionescu M (1993). Pathobiochemical changes of the arterial wall at the inception of atherosclerosis. In: Vollmer E and Roessner A, editors: Current topics in pathology 87, Berlin: Springer Verlag, 1-45.
35. Simionescu M and Simionescu N (1993). Modulations and dysfunctions in the artery intima during the prelesional stage of hypercholesterolemic atherogenesis. In: Born G. V. R. and Schwartz C. J., editors: New horizons in coronary heart disease. London: Current Science Ltd., 11.1-11.14.
36. Simionescu M, Simionescu N, Silbert JE, and Palade GE (1981). Differentiated microdomains on the luminal surface of the capillary endothelium: II - Partial characterization of their anionic sites. J Cell Biol 90:614-621.
37. Simionescu N, Vasile E, Lupu F, Popescu G, and Simionescu M (1986). Prelesional events in atherogenesis: Accumulation of extracellular cholesterol-rich liposomes in the intima and cardiac valves of the hyperlipidemic rabbit. Am J Pathol 123:109-125.
38. Tîrziu D, Dobrian A, Tasca C, Simionescu M, and Simionescu N (1995). Intimal thickening of human aorta contain modified reassembled lipoproteins. Atherosclerosis 112:101-114.
39. Van Dyk DJ, Erman A, Erman T, Chen-Gal B, Sulkes J, and Boner G (1994). Increased serum ACE activity in type T IDDM: Its relation to metabolic control and diabetic complications. Eur J Clin Invest 24:463-467.
40. Williamson JR, Rowold E, Hoffman P, and Kilo C (1976). Influence of fixation and morphometric techniques on capillary basement membrane thickening prelevance data in diabetes. Diabetes 25:604-613.
41. Witztum JL, Steinbrecher UP, Kesamimi YA, and Fisher M (1984). Autoantibodies to glucosylated proteins in the plasma of patients with diabetes mellitus. Proc Natl Acad Sci USA 81:3204-3208.
42. Wolff SP (1993). Diabetes mellitus and free radicals. Br Med Bull 49:642-652.
43. Yokota K (1984). A study of cardiac capillary casts in diabetics and nondiabetics by means of scanning electron microscope with correlation to morphometrical analysis. Jikeikai Med 31:211-228.